Literature DB >> 33536616

A gene-environment-induced epigenetic program initiates tumorigenesis.

Direna Alonso-Curbelo1, Yu-Jui Ho1, Cassandra Burdziak2,3, Jesper L V Maag4, John P Morris1, Rohit Chandwani5,6,7, Hsuan-An Chen1,8, Kaloyan M Tsanov1, Francisco M Barriga1, Wei Luan1, Nilgun Tasdemir1, Geulah Livshits1, Elham Azizi2, Jaeyoung Chun2,9, John E Wilkinson10, Linas Mazutis2,9, Steven D Leach5,11,12, Richard Koche4, Dana Pe'er2, Scott W Lowe13,14.   

Abstract

Tissue damage increases the risk of cancer through poorly understood mechanisms1. In mouse models of pancreatic cancer, pancreatitis associated with tissue injury collaborates with activating mutations in the Kras oncogene to markedly accelerate the formation of early neoplastic lesions and, ultimately, adenocarcinoma2,3. Here, by integrating genomics, single-cell chromatin assays and spatiotemporally controlled functional perturbations in autochthonous mouse models, we show that the combination of Kras mutation and tissue damage promotes a unique chromatin state in the pancreatic epithelium that distinguishes neoplastic transformation from normal regeneration and is selected for throughout malignant evolution. This cancer-associated epigenetic state emerges within 48 hours of pancreatic injury, and involves an 'acinar-to-neoplasia' chromatin switch that contributes to the early dysregulation of genes that define human pancreatic cancer. Among the factors that are most rapidly activated after tissue damage in the pre-malignant pancreatic epithelium is the alarmin cytokine interleukin 33, which recapitulates the effects of injury in cooperating with mutant Kras to unleash the epigenetic remodelling program of early neoplasia and neoplastic transformation. Collectively, our study demonstrates how gene-environment interactions can rapidly produce gene-regulatory programs that dictate early neoplastic commitment, and provides a molecular framework for understanding the interplay between genetic and environmental cues in the initiation of cancer.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33536616      PMCID: PMC8482641          DOI: 10.1038/s41586-020-03147-x

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  82 in total

Review 1.  Acinar cell plasticity and development of pancreatic ductal adenocarcinoma.

Authors:  Peter Storz
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-08       Impact factor: 46.802

2.  Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice.

Authors:  Meredith A Collins; Filip Bednar; Yaqing Zhang; Jean-Christophe Brisset; Stefanie Galbán; Craig J Galbán; Sabita Rakshit; Karen S Flannagan; N Volkan Adsay; Marina Pasca di Magliano
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

Review 3.  Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.

Authors:  Veronique Giroux; Anil K Rustgi
Journal:  Nat Rev Cancer       Date:  2017-09-01       Impact factor: 60.716

4.  Acute pancreatitis markedly accelerates pancreatic cancer progression in mice expressing oncogenic Kras.

Authors:  Catherine Carrière; Alison L Young; Jason R Gunn; Daniel S Longnecker; Murray Korc
Journal:  Biochem Biophys Res Commun       Date:  2009-03-16       Impact factor: 3.575

5.  Identification of Sox9-dependent acinar-to-ductal reprogramming as the principal mechanism for initiation of pancreatic ductal adenocarcinoma.

Authors:  Janel L Kopp; Guido von Figura; Erin Mayes; Fen-Fen Liu; Claire L Dubois; John P Morris; Fong Cheng Pan; Haruhiko Akiyama; Christopher V E Wright; Kristin Jensen; Matthias Hebrok; Maike Sander
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

6.  Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse.

Authors:  Sunil R Hingorani; Emanuel F Petricoin; Anirban Maitra; Vinodh Rajapakse; Catrina King; Michael A Jacobetz; Sally Ross; Thomas P Conrads; Timothy D Veenstra; Ben A Hitt; Yoshiya Kawaguchi; Don Johann; Lance A Liotta; Howard C Crawford; Mary E Putt; Tyler Jacks; Christopher V E Wright; Ralph H Hruban; Andrew M Lowy; David A Tuveson
Journal:  Cancer Cell       Date:  2003-12       Impact factor: 31.743

7.  Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.

Authors:  John P Morris; David A Cano; Shigeki Sekine; Sam C Wang; Matthias Hebrok
Journal:  J Clin Invest       Date:  2010-01-11       Impact factor: 14.808

8.  Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.

Authors:  Nils Habbe; Guanglu Shi; Robert A Meguid; Volker Fendrich; Farzad Esni; Huiping Chen; Georg Feldmann; Doris A Stoffers; Stephen F Konieczny; Steven D Leach; Anirban Maitra
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-21       Impact factor: 11.205

9.  In vivo lineage tracing defines the role of acinar-to-ductal transdifferentiation in inflammatory ductal metaplasia.

Authors:  Oliver Strobel; Yuval Dor; Janivette Alsina; Amy Stirman; Gregory Lauwers; Amanda Trainor; Carlos Fernández-Del Castillo; Andrew L Warshaw; Sarah P Thayer
Journal:  Gastroenterology       Date:  2007-09-14       Impact factor: 22.682

10.  Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.

Authors:  Carmen Guerra; Alberto J Schuhmacher; Marta Cañamero; Paul J Grippo; Lena Verdaguer; Lucía Pérez-Gallego; Pierre Dubus; Eric P Sandgren; Mariano Barbacid
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

View more
  29 in total

1.  Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer.

Authors:  Aftab Alam; Eric Levanduski; Parker Denz; Helena Solleiro Villavicencio; Maulasri Bhatta; Lamees Alhorebi; Yali Zhang; Eduardo Cortes Gomez; Brian Morreale; Sharon Senchanthisai; Jun Li; Steven G Turowski; Sandra Sexton; Sheila Jani Sait; Prashant K Singh; Jianmin Wang; Anirban Maitra; Pawel Kalinski; Ronald A DePinho; Huamin Wang; Wenting Liao; Scott I Abrams; Brahm H Segal; Prasenjit Dey
Journal:  Cancer Cell       Date:  2022-02-03       Impact factor: 31.743

Review 2.  Clinical relevance of tumour-associated macrophages.

Authors:  Mikael J Pittet; Olivier Michielin; Denis Migliorini
Journal:  Nat Rev Clin Oncol       Date:  2022-03-30       Impact factor: 66.675

Review 3.  Inflammatory memory and tissue adaptation in sickness and in health.

Authors:  Shruti Naik; Elaine Fuchs
Journal:  Nature       Date:  2022-07-13       Impact factor: 69.504

Review 4.  Cellular and molecular mechanisms of plasticity in cancer.

Authors:  Stefan R Torborg; Zhuxuan Li; Jason E Chan; Tuomas Tammela
Journal:  Trends Cancer       Date:  2022-05-23

5.  Pancreatic tumor initiation: the potential role of IL-33.

Authors:  Xing Huang; Gang Zhang; Tingbo Liang
Journal:  Signal Transduct Target Ther       Date:  2021-05-22

Review 6.  The biology of pancreatic cancer morphology.

Authors:  Oliver G McDonald
Journal:  Pathology       Date:  2021-12-03       Impact factor: 5.306

7.  Mutation alters chromatin changes during injury response to drive cancer.

Authors:  Dane Vassiliadis; Mark A Dawson
Journal:  Nature       Date:  2021-02       Impact factor: 69.504

8.  A phase I study of the safety and activity of K-001 in patients with advanced pancreatic ductal adenocarcinoma.

Authors:  Jiujie Cui; Haiyan Yang; Jue Liu; Donghui Chen; Jiong Hu; Haiyan Zhang; Yu Wang; Ting Han; Tiebo Mao; Feng Jiao; Ewelina Biskup; Yaotian Pan; Min Liu; Liwei Wang
Journal:  BMC Cancer       Date:  2021-06-07       Impact factor: 4.430

Review 9.  The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma.

Authors:  Jorge Melendez-Zajgla; Vilma Maldonado
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

10.  A Transcriptionally Distinct Subpopulation of Healthy Acinar Cells Exhibit Features of Pancreatic Progenitors and PDAC.

Authors:  Vishaka Gopalan; Arashdeep Singh; Farid Rashidi Mehrabadi; Li Wang; Eytan Ruppin; H Efsun Arda; Sridhar Hannenhalli
Journal:  Cancer Res       Date:  2021-05-28       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.